Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UBE2T | Q9NPD8 | 1/20 | 0.59 |
| ▸ | ASIC3 | Q9UHC3 | 1/20 | 0.59 |
| ▸ | NPC1 | O15118 | 5/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.51 |
| ▸ | RAB9A | P51151 | 5/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.51 |
| ▸ | MAPT | P10636 | 3/20 | 0.51 |
| ▸ | HTT | P42858 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 3/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fluoride SCHEMBL2461456 | 0.98 | UBE2T (0.58) | UBE2TASIC3NPC1SMN1; SMN2RAB9A | |
| Benzo[D]Thiazole SCHEMBL25268972 | 0.88 | ALDH1A1 (0.54) | UBE2TASIC3NPC1SMN1; SMN2RAB9A | |
| SCHEMBL10425906 | 0.84 | NPC1 (0.48) | UBE2TASIC3NPC1SMN1; SMN2RAB9A | |
| SCHEMBL6001358 | 0.82 | UBE2T (0.56) | UBE2TASIC3NPC1SMN1; SMN2RAB9A | |
| SCHEMBL620659 | 0.81 | UBE2T (0.59) | UBE2TASIC3NPC1SMN1; SMN2RAB9A | |
| SCHEMBL1077024 | 0.81 | UBE2T (0.59) | UBE2TASIC3NPC1SMN1; SMN2RAB9A | |
| SCHEMBL6013468 | 0.79 | UBE2T (0.56) | UBE2TASIC3NPC1SMN1; SMN2RAB9A | |
| SCHEMBL9698399 | 0.79 | UBE2T (0.61) | UBE2TASIC3NPC1SMN1; SMN2RAB9A | |
| SCHEMBL288477 | 0.79 | UBE2T (0.66) | UBE2TASIC3NPC1SMN1; SMN2RAB9A | |
| SCHEMBL3115155 | 0.79 | UBE2T (0.66) | UBE2TASIC3NPC1SMN1; SMN2RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 171 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4441112-A1 | METHOD OF UNDERWATER BONDING | Henkel AG & Co. KGaA (DE) | 2024-10-09 | — | — | EP | claimed |
| US-20240318052-A1 | METHOD OF UNDERWATER BONDING | HENKEL AG & CO KGAA (DE) | 2024-09-26 | — | — | US | claimed |
| CN-118355041-A | Method for underwater bonding | 汉高股份有限及两合公司 | 2024-07-16 | — | — | CN | claimed |
| CN-109314187-B | Solvent blend for photoactive layers | 剑桥显示技术有限公司 | 2023-08-29 | — | — | CN | claimed |
| WO-2023099777-A1 | METHOD OF UNDERWATER BONDING | Henkel IP & Holding GmbH (DE) | 2023-06-08 | — | — | WO | claimed |
| CN-111420709-B | Application of N-heterocyclic carbene-based mixed nickel (II) complex in synthesis of 2-linear alkyl benzothiazole compound | 苏州大学 | 2023-06-06 | — | — | CN | claimed |
| EP-3275980-B1 | LUBRICANT OIL COMPOSITION FOR SPARK IGNITION TYPE INTERNAL COMBUSTION ENGINE, METHOD FOR PRODUCING LUBRICANT OIL COMPOSITION, SPARK IGNITION TYPE INTERNAL COMBUSTION ENGINE USING LUBRICANT OIL COMPOSITION, AND METHOD FOR LUBRICATING INTERNAL COMBUSTION ENGINE | IDEMITSU KOSAN CO (JP) | 2023-05-03 | — | — | EP | claimed |
| CN-114276311-B | Method for synthesizing aryl oxazole compound by using nickel complex as catalyst | 上海应用技术大学 | 2023-03-31 | — | — | CN | claimed |
| CN-114315594-B | Method for catalytically synthesizing chiral amine compound by using rhodium complex | 上海应用技术大学 | 2023-03-31 | — | — | CN | claimed |
| CN-112810273-B | Release film containing 4-methyl-1-pentene polymer and preparation method thereof | 苏州市新广益电子股份有限公司 | 2023-02-24 | — | — | CN | claimed |
| US-20140024565-A1 | Nanoparticle Compositions and Methods for Making and Using the Same | BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS (US) | 2014-01-23 | — | — | US | claimed |
| EP-1592426-B1 | 2-CYANOPYRROLOPYRIMIDINES AND PHARMACEUTICAL USES THEREOF | NOVARTIS AG (CH) | 2007-12-19 | — | — | EP | claimed |
| US-20060247251-A1 | 2-Cyanopyrrolopyrimidines and pharmaceutical uses thereof | NOVARTIS AG (CH) | 2006-11-02 | — | — | US | claimed |
| CN-1756553-A | 2-cyanopyrrolopyrimidines and pharmaceutical uses thereof | NOVARTIS AG (CH) | 2006-04-05 | — | — | CN | claimed |
| EP-1592426-A1 | 2-CYANOPYRROLOPYRIMIDINES AND PHARMACEUTICAL USES THEREOF | Novartis AG (CH) | 2005-11-09 | — | — | EP | claimed |
| US-20040168748-A1 | Addition product, production and use thereof as corrosion inhibitor | FRAUNHOFER-GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) | 2004-09-02 | — | — | US | claimed |
| WO-2004069256-A1 | 2-CYANOPYRROLOPYRIMIDINES AND PHARMACEUTICAL USES THEREOF | NOVARTIS AG (CH) | 2004-08-19 | — | — | WO | claimed |
| EP-1373599-A2 | ADDITION PRODUCT, PRODUCTION AND USE THEREOF AS CORROSION INHIBITOR | FRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) | 2004-01-02 | — | — | EP | claimed |
| WO-2002090619-A2 | ADDITION PRODUCT, PRODUCTION AND USE THEREOF AS CORROSION INHIBITOR | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2002-11-14 | — | — | WO | claimed |
| US-4840862-A | HIGH SENSITIVITY AND STABILITY | FUJI PHOTO FILM CO., LTD. (JP) | 1989-06-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060247251-A1 | 2-Cyanopyrrolopyrimidines and pharmaceutical uses thereof | DPYD, P2RY1, P2RY2 | UBE2T 3769/4885ASIC3 2086/4885NPC1 2729/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.